Literature DB >> 9710950

Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing.

I F Purchase1, P A Botham, L H Bruner, O P Flint, J M Frazier, W S Stokes.   

Abstract

Public concern for animal welfare has been expressed through legislative control of animal use for experimental purposes since the first legislation was introduced in 1876 in the United Kingdom. Legislative control of animal use has been introduced in virtually every developed country, with major initiatives in Europe (1986) and the United States (1966 and 1985). Advances in scientific thinking resulted in the development of the concept of the three Rs--refinement, reduction, and replacement--by Russell and Burch in 1959. The field has expanded substantially since, with specialist scientific journals dedicated to alternatives, World Congresses organized to discuss the scientific and philosophical issues, and European and U.S. validation organizations being launched. Current scientific attention is focused on validation of alternative methods. The underlying scientific principles of chemical toxicity are complicated and insufficiently understood for alternative methods for all toxicity endpoints of importance in protecting human health to be available. Important lessons have been learned about how to validate methods, including the need to have prediction models available before the validation is undertaken, the need to understand the variability of the animal-based data which is to be used as the validation standard, and the need to have well-managed validation programs. Future progress will depend on the development of novel methods, which can now be validated through international collaborative efforts.

Entities:  

Mesh:

Year:  1998        PMID: 9710950     DOI: 10.1006/toxs.1998.2450

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  2 in total

1.  Crotalus durissus collilineatus Venom Induces TNF- α and IL-10 Production in Human Peripheral Blood Mononuclear Cells.

Authors:  Camila Bastos Ribeiro; Jéssica Cristina Dos Santos; Jacyelle Medeiros Silva; Pedro Henrique Silva de Godoi; Marta Regina Magalhães; Mônica Spadafora-Ferreira; Simone Gonçalves Fonseca; Irmtraut Araci Hoffman Pfrimer
Journal:  ISRN Inflamm       Date:  2014-01-19

2.  Factor XII-Deficient Chicken Plasma as a Useful Target for Screening of Pro- and Anticoagulant Animal Venom Toxins.

Authors:  Benedito C Prezoto; Nancy Oguiura
Journal:  Toxins (Basel)       Date:  2020-01-23       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.